We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+17.59%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.32B
AUM Growth
+$305M
Cap. Flow
-$111M
Cap. Flow %
-3.35%
Top 10 Hldgs %
27.26%
Holding
347
New
20
Increased
106
Reduced
158
Closed
17

Top Buys

Rank Stock Value
1
MNDY icon
monday.com
MNDY
+$28.5M
2
BIRK icon
Birkenstock
BIRK
+$8.8M
3
VCEL icon
Vericel Corp
VCEL
+$8.79M
4
CWAN
Clearwater Analytics
CWAN
+$8.42M
5
ALKS icon
Alkermes
ALKS
+$7.88M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$13.7M
2
GTLS
Chart Industries
GTLS
+$10.7M
3
PLNT icon
Planet Fitness
PLNT
+$9.58M
4
AZEK
The AZEK Co
AZEK
+$9.1M
5
ADBE icon
Adobe
ADBE
+$8.7M

Sector Composition

Rank Sector Weight
1 Technology 31.16%
2 Financials 15.52%
3 Healthcare 15.45%
4 Consumer Discretionary 13.62%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
101
Insmed
INSM
$29.3B
$8.93M 0.27%
88,695
-92,298
-51% -$7.06M
LTH icon
102
Life Time Group Holdings
LTH
$9.73B
$8.72M 0.26%
287,654
+4,739
+2% +$141K
TFIN icon
103
Triumph Financial Inc
TFIN
$1.82B
$8.67M 0.26%
157,305
-24,017
-13% -$1.34M
RAMP icon
104
LiveRamp
RAMP
$2.3B
$8.56M 0.26%
259,033
+9,693
+4% +$282K
NBIX icon
105
Neurocrine Biosciences
NBIX
$16.6B
$8.43M 0.25%
67,069
-5,903
-8% -$677K
BIRK icon
106
Birkenstock
BIRK
$6.98B
$8.42M 0.25%
+171,249
New +$8.8M
CECO icon
107
Ceco Environmental
CECO
$4.21B
$8.35M 0.25%
294,949
+54,397
+23% +$1.35M
ADMA icon
108
ADMA Biologics
ADMA
$2.22B
$8.32M 0.25%
456,656
+53,515
+13% +$1.09M
NCNO icon
109
nCino
NCNO
$2.11B
$8.22M 0.25%
293,994
+4,826
+2% +$121K
ADPT icon
110
Adaptive Biotechnologies
ADPT
$4.1B
$8.19M 0.25%
+702,711
New +$6.38M
KNX icon
111
Knight Transportation
KNX
$11.1B
$8.11M 0.24%
183,339
-2,909
-2% -$124K
ALGM icon
112
Allegro MicroSystems
ALGM
$7.94B
$8.03M 0.24%
234,925
-33,491
-12% -$834K
CWAN
113
DELISTED
Clearwater Analytics
CWAN
$8.03M 0.24%
+365,990
New +$8.42M
OCUL icon
114
Ocular Therapeutix
OCUL
$2.1B
$8M 0.24%
861,962
+14,494
+2% +$113K
KNSA icon
115
Kiniksa Pharmaceuticals
KNSA
$6.08B
$7.99M 0.24%
288,636
-20,554
-7% -$523K
BLFS icon
116
BioLife Solutions
BLFS
$1.71B
$7.98M 0.24%
370,663
+6,217
+2% +$140K
SPRY icon
117
ARS Pharmaceuticals
SPRY
$584M
$7.97M 0.24%
456,979
-44,842
-9% -$647K
TWST icon
118
Twist Bioscience
TWST
$7.76B
$7.97M 0.24%
+216,582
New +$7.48M
R icon
119
Ryder
R
$9.99B
$7.96M 0.24%
50,032
-8,245
-14% -$1.21M
WGS icon
120
GeneDx Holdings
WGS
$2.42B
$7.92M 0.24%
+85,763
New +$6.73M
EVH icon
121
Evolent Health
EVH
$471M
$7.92M 0.24%
703,038
+181,980
+35% +$1.67M
PRVA icon
122
Privia Health
PRVA
$2.81B
$7.9M 0.24%
343,292
+13,162
+4% +$305K
TMDX icon
123
Transmedics
TMDX
$3B
$7.87M 0.24%
58,730
-9,660
-14% -$1.06M
DBRG icon
124
DigitalBridge
DBRG
$2.95B
$7.87M 0.24%
759,909
+137,793
+22% +$1.31M
DAR icon
125
Darling Ingredients
DAR
$9.92B
$7.7M 0.23%
202,912
-15,894
-7% -$523K
3 4
5
6 7

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Peregrine Capital Management held 347 positions worth $3.32B, up 10% from $3.01B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Peregrine Capital Management withdrew a net $111M in Q2 2025, closing 17 positions and reducing 158 holdings. Its most notable exit was The AZEK Co, an estimated $9.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Peregrine Capital Management opened a new position in monday.com worth $32.2M.

  • Peregrine Capital Management's largest Q2 2025 buy was monday.com: 102,388 shares worth $32.2M.
  • Peregrine Capital Management added most to Exact Sciences in Q2 2025, an estimated $5.96M increase.
  • Peregrine Capital Management's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $13.7M.
  • Peregrine Capital Management fully exited The AZEK Co in Q2 2025, selling an estimated $9.1M.
  • Peregrine Capital Management's ten largest holdings make up 27% of its $3.32B portfolio in Q2 2025.
  • Peregrine Capital Management opened 20 new positions and closed 17 in Q2 2025.
  • Peregrine Capital Management's portfolio value rose 10% quarter-over-quarter to $3.32B.

Based on Peregrine Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.